SCHEMBL5501098

SCHEMBL5501098

CCCCn1nc(CC)c2c(oc3c(OC(F)F)cccc32)c1=O

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MPO P05164 3/20 0.34
POLB P06746 2/20 0.34
PDE4A P27815 3/20 0.33
PDE4B Q07343 3/20 0.33
PDE4C Q08493 3/20 0.33
PDE4D Q08499 3/20 0.33
RAB9A P51151 2/20 0.33
PDE3B Q13370 2/20 0.33
PDE3A Q14432 2/20 0.33
ALDH1A1 P00352 2/20 0.33
KDM4E B2RXH2 1/20 0.33
GLA P06280 1/20 0.33
GAA P10253 1/20 0.33
MAPT P10636 1/20 0.33
HPGD P15428 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
NPC1 O15118 1/20 0.33
CNR2 P34972 2/20 0.32
ALOX15 P16050 1/20 0.32
CRHR1 P34998 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5501126 0.90 ADORA2A (0.39) PDE4APDE4BPDE4CPDE4DMAPT
SCHEMBL73917 0.68 PDE4D (0.36) PDE4APDE4BPDE4CPDE4D
SCHEMBL5504865 0.66 ALDH1A1 (0.39) PDE4APDE4BPDE4CPDE4DALDH1A1
SCHEMBL3878942 0.65 EIF4A1 (0.33) PDE4APDE4BPDE4CPDE4DRAB9A
SCHEMBL31427197 0.63 ADRA1A (0.42) MPOALDH1A1KDM4ETNFLITAF
SCHEMBL16363661 0.61 ALOX15 (0.48) MPOPOLBPDE4APDE4BPDE4C
SCHEMBL15041024 0.61 BACE1 (0.32) PDE4APDE4BPDE4CPDE4DNPC1
SCHEMBL31427220 0.60 ADRA1A (0.40) ALDH1A1KDM4EMAPTHPGDTNF
SCHEMBL16363659 0.59 TSHR (0.64) POLBPDE4APDE4BPDE4CPDE4D
SCHEMBL31427207 0.59 RECQL (0.43) ALDH1A1KDM4EMAPTTNFLITAF

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1831227-A2 NOVEL HETEROCYCLIC COMPOUNDS USEFUL FOR THE TREATMENT OF INFLAMMATORY AND ALLERGIC DISORDERS Glenmark Pharmaceuticals S.A. (CH) 2007-09-12 EP claimed
WO-2006064355-A2 NOVEL HETEROCYCLIC COMPOUNDS USEFUL FOR THE TREATMENT OF INFLAMMATORY AND ALLERGIC DISORDERS GLENMARK PHARMACEUTICALS S.A. (US) 2006-06-22 WO claimed